首页> 外文期刊>Hepatology: Official Journal of the American Association for the Study of Liver Diseases >Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis.
【24h】

Critical role of tumor necrosis factor receptor 1, but not 2, in hepatic stellate cell proliferation, extracellular matrix remodeling, and liver fibrogenesis.

机译:肿瘤坏死因子受体1(而非2)在肝星状细胞增殖,细胞外基质重塑和肝纤维化中的关键作用。

获取原文
获取原文并翻译 | 示例
           

摘要

Tumor necrosis factor (TNF) has been implicated in the progression of many chronic liver diseases leading to fibrosis; however, the role of TNF in fibrogenesis is controversial and the specific contribution of TNF receptors to hepatic stellate cell (HSC) activation remains to be established. Using HSCs from wild-type, TNF-receptor-1 (TNFR1) knockout, TNF-receptor-2 (TNFR2) knockout, or TNFR1/R2 double-knockout (TNFR-DKO) mice, we show that loss of both TNF receptors reduced procollagen-alpha1(I) expression, slowed down HSC proliferation, and impaired platelet-derived growth factor (PDGF)-induced promitogenic signaling in HSCs. TNFR-DKO HSCs exhibited decreased AKT phosphorylation and in vitro proliferation in response to PDGF. These effects were reproduced in TNFR1 knockout, but not TNFR2 knockout, HSCs. In addition, matrix metalloproteinase 9 (MMP-9) expression was dependent on TNF binding to TNFR1 in primary mouse HSCs. These results were validated in the human HSC cell line, LX2, using neutralizing antibodies against TNFR1 and TNFR2. Moreover, in vivo liver damage and fibrogenesis after bile-duct ligation were reduced in TNFR-DKO and TNFR1 knockout mice, compared to wild-type or TNFR2 knockout mice. CONCLUSION: TNF regulates HSC biology through its binding to TNFR1, which is required for HSC proliferation and MMP-9 expression. These data indicate a regulatory role for TNF in extracellular matrix remodeling and liver fibrosis, suggesting that targeting TNFR1 may be of benefit to attenuate liver fibrogenesis.
机译:肿瘤坏死因子(TNF)与许多导致肝纤维化的慢性肝脏疾病有关。然而,TNF在纤维发生中的作用是有争议的,并且TNF受体对肝星状细胞(HSC)活化的特异性作用尚待确定。使用野生型,TNF-受体-1(TNFR1)敲除,TNF-受体-2(TNFR2)敲除或TNFR1 / R2双敲除(TNFR-DKO)小鼠的HSC,我们证明两种TNF受体的损失均减少procollagen-alpha1(I)的表达,减缓HSC的增殖,并损害HSCs中血小板衍生的生长因子(PDGF)诱导的促细胞生成信号。 TNFR-DKO HSC表现出降低的AKT磷酸化和响应PDGF的体外增殖。这些效应在TNFR1基因敲除,而不在TNFR2基因敲除,HSC中复制。此外,基质金属蛋白酶9(MMP-9)的表达依赖于原发性小鼠HSC中TNF与TNFR1的结合。这些结果已在人HSC细胞系LX2中使用抗TNFR1和TNFR2的中和抗体进行了验证。此外,与野生型或TNFR2敲除小鼠相比,TNFR-DKO和TNFR1敲除小鼠体内胆管结扎后的肝损伤和纤维形成减少。结论:TNF通过与HSR增殖和MMP-9表达所需的TNFR1结合来调节HSC生物学。这些数据表明TNF在细胞外基质重塑和肝纤维化中的调节作用,表明靶向TNFR1可能有益于减轻肝纤维化。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号